The Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Advanced Therapeutics Pharmaceutical Outsourcing Market:
https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report
According to The Business Research Company’s Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2024, The advanced therapeutics pharmaceutical outsourcing market size is expected to see steady growth in the next few years. It will grow to $9.76 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to The increasing adoption of cell and gene therapies, The increasing focus on mRNA therapies, rising demand for cutting-edge treatments, improved efficiency and cost-effective solutions provided by outsourcing partners, and collaborative innovation. Major trends in the forecast period include technological advancement, rising expertise in advanced therapeutics, escalating pipeline of innovative therapies, the integration of cutting-edge technology, rapid advancements in gene therapy, cell therapy, and mRNA technologies.
The increasing adoption of cell and gene therapies is expected to propel the growth of the advanced therapeutics pharmaceutical outsourcing market going forward. Cell and gene therapies are innovative treatments that use living cells or genetic material to treat or cure diseases. Advanced therapeutics pharmaceutical outsourcing is used in cell and gene therapies to offer access to providers with proven track records and experienced personnel, saving companies time and resources in building their teams. For instance, in November 2023, according to a report by Nature, a UK-based scientific journal, the number of new patients treated with gene therapies is expected to increase from 16,244 in 2020 to 94,696 in 2025. Therefore, the increasing adoption of cell and gene therapies is driving the growth of the advanced therapeutics pharmaceutical outsourcing market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are focusing on strategic partnerships to provide reliable services to customers. A strategic partnership is a collaborative arrangement between two or more entities (typically businesses) formed to achieve mutually beneficial goals that each partner could not achieve independently. For instance, in January 2023, Lonza, a Switzerland-based manufacturing company for the pharmaceutical, biotechnology, and nutrition sectors, partnered with Context Therapeutics Inc., a US-based biopharmaceutical company advancing medicines for solid tumors. The partnership involves Lonza providing manufacturability assessment, gene, and cell line construction, and process development for the drug substance and drug product.
The advanced therapeutics pharmaceutical outsourcing market report table of contents includes:
1. Executive Summary
2.Advanced Therapeutics Pharmaceutical Outsourcing Market Characteristics
3.Advanced Therapeutics Pharmaceutical Outsourcing Market Trends And Strategies
4.Advanced Therapeutics Pharmaceutical Outsourcing market analysis
5Advanced Therapeutics Pharmaceutical Outsourcing. Market Size And Growth
6.Advanced Therapeutics Pharmaceutical Outsourcing Segmentation
7.Advanced Therapeutics Pharmaceutical Outsourcing Regional And Country Analysis
.
.
.
27.Advanced Therapeutics Pharmaceutical Outsourcing Competitive Landscape And Company Profiles
28.Advanced Therapeutics Pharmaceutical Outsourcing Key Mergers And Acquisitions
29.Advanced Therapeutics Pharmaceutical Outsourcing Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
- IQVIA
- ICON plc
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
